ginsenoside rh2 has been researched along with transforming growth factor beta in 3 studies
Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
---|---|---|---|---|---|
295 | 1 | 200 | 49,119 | 560 | 17,610 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, SH; Choi, JH; Choi, SY; Chung, KS; Hong, HD; Kim, DH; Lee, KT; Rhee, YK; Shin, JS | 1 |
Guo, C; Wu, Q; Ye, H; Zheng, X; Zhu, Y | 1 |
Kim, JH; Kim, K; Kim, M; Kim, YB; Lee, S; No, JH; Suh, DH; Yun, SM | 1 |
3 other study(ies) available for ginsenoside rh2 and transforming growth factor beta
Article | Year |
---|---|
Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-β expression.
Topics: Apoptosis; Blotting, Western; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Differentiation; Cell Proliferation; Drugs, Chinese Herbal; G1 Phase; Ginsenosides; Humans; Immunoprecipitation; Leukemia; Phosphorylation; Real-Time Polymerase Chain Reaction; Retinoblastoma Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Tumor Cells, Cultured | 2013 |
Ginsenoside Rh2 alleviates dextran sulfate sodium-induced colitis via augmenting TGFβ signaling.
Topics: Animals; Colitis; Colon; Dextran Sulfate; Ginsenosides; Male; Mice; Mice, Inbred C57BL; Signal Transduction; Transforming Growth Factor beta | 2014 |
Ginsenoside Rh2 induces apoptosis and inhibits epithelial-mesenchymal transition in HEC1A and Ishikawa endometrial cancer cells.
Topics: Apoptosis; Cadherins; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endometrial Neoplasms; Epithelial-Mesenchymal Transition; Female; Ginsenosides; Humans; In Situ Nick-End Labeling; Signal Transduction; Transforming Growth Factor beta; Vimentin | 2017 |